Paquinimod‐hydrogel hybrid microneedle array patch alleviates hypertrophic scar via inhibiting M1 polarization
Bioengineering & Translational Medicine,
Год журнала:
2025,
Номер
unknown
Опубликована: Март 15, 2025
Abstract
Hypertrophic
scar
(HS)
is
one
of
the
most
common
complications
skin
injuries,
with
a
lack
effective
therapeutic
approaches
to
date.
Most
current
research
has
focused
on
dysfunction
hypertrophic
fibroblasts
(HSFBs)
and
dermal
vascular
endothelial
cells
(HDVECs),
neglecting
crucial
role
inflammatory
microenvironment
that
causes
them
be
abnormal.
In
this
study,
we
first
discovered
validated
S100A8/9
specific
inhibitor
Paquinimod
could
inhibit
macrophage
polarization
toward
M1,
further
suppress
proliferation,
migration,
collagen
formation,
angiogenesis
HSFBs
HDVECs
in
vitro.
This
mechanism
also
been
rat
model
HS.
Then,
developed
good
biocompatibility
penetrability
Paquinimod‐Hydrogel
Hybrid
Microneedle
Array
Patch
(PHMAP)
for
HS
treatment.
With
advantages
excellent
penetrability,
surface
sealing,
sustained
release,
precise
uniform
distribution,
PHMAP
exhibited
superior
efficacy
over
intravenous
intradermal
injections.
These
results
suggest
can
promising
advanced
solution
prevention
therapies.
Язык: Английский
The immunosuppressive role of MDSCs in HCC: mechanisms and therapeutic opportunities
Cell Communication and Signaling,
Год журнала:
2025,
Номер
23(1)
Опубликована: Март 27, 2025
Hepatocellular
carcinoma
(HCC)
is
a
prevalent
malignancy
with
significant
global
burden.
Despite
substantial
advancements
in
HCC
treatment
recent
years,
therapeutic
efficacy
remains
constrained
by
immune
evasion
mechanisms
within
the
tumor
microenvironment
(TME).
Myeloid-derived
suppressor
cells
(MDSCs),
as
critical
immunosuppressive
elements
of
TME,
have
garnered
increasing
attention
for
their
role
progression.
Recent
studies
emphasize
central
involvement
promoting
evasion,
tolerance,
and
immunosuppression
HCC.
This
review
examines
contributions
MDSCs
to
pathogenesis,
elucidates
underlying
mechanisms,
discusses
ongoing
clinical
trials,
emphasizing
potential
targets
improving
outcomes.
Язык: Английский